Obesity hypoventilation syndrome (OHS)
Obesity hypoventilation syndrome (OHS) is defined as chronic daytime hypercapnia in obese patients (those with a BMI of > 30kg/m2) with a daytime PaCO2 of over 45 mmHg, after ruling out any other causes of hypoventilation.1
As many as 90% of patients with OHS also suffer from obstructive sleep apnoea (OSA).2
What is OHS?
OHS is defined as chronic daytime hypercapnia in obese patients after ruling out any other causes of hypoventilation.
Treatment options for obesity hypoventilation syndrome
Recommended treatment options for OHS include controlled weight loss and noninvasive ventilation.
Getting the most out of ventilation therapy
Adhering to therapy is critical for patients receiving noninvasive ventilation.
Patient outcomes
Learn about the positive outcomes for OHS patients being treated with NIV.
Equipment replacement
Educate patients on the importance of timely equipment replacement and how critical it is to the success of their sleep apnoea therapy.
References
- Olson AL, Zwillich C.The obesity hypoventilation syndrome.Am J Med. 2005 Sep; 118(9): 948-56.
- Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, Weitzenblum E. (2001) The obesity-hypoventilation syndrome revisited: A prospective study of 34 consecutive cases. Chest 120:369-376.
